ASCO Releases Vaccination Guidelines for Adults With CancerMarch 28, 2024Preventive CareImmuno-oncologyLung CancerMelanomaASCO Breast CancerASCO Lung Cancer
My picks for best of ASCO 2022June 28, 2022ASCO Lung CancerASCO Breast CancerBreast CancerGenitourinary CancerGynecologic CancerLung CancerMetastatic Breast Cancer
Patients with blood cancers underutilize palliative careJune 23, 2022Patient & Survivor CareASCO Lung CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPractice Management
Promising treatment option for incurable lung cancer described as ‘significant’June 13, 2022Lung CancerASCO Lung Cancer
Oncologists flock to Chicago for ASCO, after 2 years onlineJune 3, 2022ASCO Breast CancerASCO Lung Cancer
HER3-targeted treatment demonstrates efficacy and safety in phase 1 lung cancer studyJune 11, 2021Lung CancerASCO Lung Cancer
Surgical outcomes favor addition of nivolumab to neoadjuvant chemo in resectable lung cancersJune 10, 2021Lung CancerASCO Lung Cancer
Vinorelbine survival benefit in mesothelioma overshadowed by advances in immuno-oncologyJune 10, 2021Lung CancerASCO Lung Cancer
Community practice lung cancer patients insufficiently tested for treatment-related biomarkersJune 6, 2021Lung CancerASCO Lung Cancer
NSCLC: Immune-related AEs during checkpoint inhibitor therapy may predict outcomesJune 6, 2021Lung CancerASCO Lung Cancer
